Anthem Biosciences Limited
Edelweiss Mutual Fund bought 3,35,661 shares of Anthem Biosciences for ₹25.00 Cr at ₹744.80 apiece in a block deal. This was part of a larger transaction where various institutional investors acquired a 3.05% stake from promoter Aruna Ganesh, who fully exited the company.
A biotechnology company providing contract research, development, and manufacturing services alongside specialty ingredients production. Established in 2006, the company serves pharmaceutical and nutraceutical sectors through its integrated CRDMO capabilities and custom synthesis expertise. Its distinctive position lies in combining comprehensive development expertise with in-house manufacturing facilities, enabling end-to-end solutions for clients requiring specialized ingredient formulation, process optimization, and commercial-scale production services.
AMC subsidiary of Edelweiss Financial Services. Manages over Rs 1.5 lakh crore across equity, debt, hybrid and alternative strategies. CEO Radhika Gupta is the most prominent woman leader in Indian asset management and has built a strong direct investor franchise through social media and investor education. Known for multi-asset and international fund-of-fund offerings.